Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Lemaitre Vascular (LMAT) over the last 17 years, with Q3 2025 value amounting to $0.75.

  • Lemaitre Vascular's EPS (Weighted Average and Diluted) rose 5306.12% to $0.75 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.31, marking a year-over-year increase of 2622.95%. This contributed to the annual value of $1.91 for FY2024, which is 4279.65% up from last year.
  • Latest data reveals that Lemaitre Vascular reported EPS (Weighted Average and Diluted) of $0.75 as of Q3 2025, which was up 5306.12% from $0.6 recorded in Q2 2025.
  • Over the past 5 years, Lemaitre Vascular's EPS (Weighted Average and Diluted) peaked at $0.75 during Q3 2025, and registered a low of $0.16 during Q2 2022.
  • Its 5-year average for EPS (Weighted Average and Diluted) is $0.38, with a median of $0.36 in 2023.
  • Per our database at Business Quant, Lemaitre Vascular's EPS (Weighted Average and Diluted) skyrocketed by 13529.41% in 2021 and then crashed by 6000.0% in 2022.
  • Lemaitre Vascular's EPS (Weighted Average and Diluted) (Quarter) stood at $0.29 in 2021, then fell by 14.59% to $0.25 in 2022, then soared by 53.72% to $0.38 in 2023, then grew by 24.81% to $0.47 in 2024, then soared by 59.17% to $0.75 in 2025.
  • Its EPS (Weighted Average and Diluted) was $0.75 in Q3 2025, compared to $0.6 in Q2 2025 and $0.48 in Q1 2025.